XML 38 R26.htm IDEA: XBRL DOCUMENT
v3.25.1

Stockholders’ Equity (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2025
Stockholders’ Equity (Deficit) [Abstract] |
Schedule of Stock Options Awards Activity | The Company recognized stock-based compensation expense during the three months ended March 31, 2025 and 2024, as follows:
|  | Three months ended March, |
|  | 2025 |  |  | 2024 |
Performance-based restricted stock awards |  | $ | - |  |  | $ | 55,983 |
Service-based restricted stock awards |  |  | 2,100,504 |  |  |  | 6,180,528 |
Option expense* |  |  | - |  |  |  | (1,335,027 | )
Total stock-based compensation |  | $ | 2,100,504 |  |  | $ | 4,901,484 |
* | The option expense for the three months ended March 31, 2024, contains a reversal of stock-based compensation expenses from 2023 for cancelled option awards.
Schedule of Performance-Based Restricted Stock Awards Activity | The following table presents a summary of the Company’s performance-based restricted stock awards activity:
|  | Number of shares |  |  | Weighted Average Remaining Contractual Life (in years) |
Outstanding as of December 31, 2024 |  |  | 72,101 |  |  |  | 7.56 |
Exercised |  |  | - |  |  |  | - |
Expired/forfeited |  |  | - |  |  |  | - |
Outstanding as of March 31, 2025 |  |  | 72,101 |  |  |  | 7.31 |
Exercisable as of March 31, 2025 |  |  | 72,101 |  |  |  | 7.31 |
The following table presents a summary of the Company’s service-based awards activity:
|  | Number of shares |  |  | Weighted Average Remaining Contractual Life (in years) |
Outstanding as of December 31, 2024 |  |  | 14,178,458 |  |  |  | 1.30 |
Issued |  |  | 1,235,030 |  |  |  | - |
Forfeited/cancelled |  |  | (72,047 | ) |  |  | - |
Outstanding as of March 31, 2025 |  |  | 15,341,441 |  |  |  | 0.99 |
Exercisable as of March 31, 2025 |  |  | 1,921,566 |  |  |  | 0.01 |
Schedule of Stock Options Awards Activity | The following table presents a summary of the Company’s Stock options awards activity:
|  | Number of shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Life (in years) |  |  | Aggregate Intrinsic Value |
Outstanding as of December 31, 2024 |  |  | 3,500,417 |  |  | $ | 1.07 |  |  |  | 9.20 |  |  | $ | - |
Issued |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Outstanding as of March 31, 2025 |  |  | 3,500,417 |  |  | $ | 1.07 |  |  |  | 8.95 |  |  | $ | - |
Exercisable as of March 31, 2025 |  |  | 3,500,417 |  |  | $ | 1.07 |  |  |  | - |  |  | $ | - |

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration